QQ客服 官方微博 反馈留言

	The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
	An, Yuan; Liu, Tian; He, Dongyi; Wu, Lijun; Li, Juan; Liu, Yi; Bi, Liqi; Zhou, Bin; Lin, Changsong; He, Lan
刊名	CLINICAL RHEUMATOLOGY
	2017
卷号	36页码:35-43
关键词	Rheumatoid arthritis China Therapy Duration Biological DMARD
ISSN号	0770-3198
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2946024
专题	西安交通大学
推荐引用方式 GB/T 7714	An, Yuan,Liu, Tian,He, Dongyi,et al. The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study[J]. CLINICAL RHEUMATOLOGY,2017,36:35-43.
APA	An, Yuan.,Liu, Tian.,He, Dongyi.,Wu, Lijun.,Li, Juan.,...&Li, Zhanguo.(2017).The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.CLINICAL RHEUMATOLOGY,36,35-43.
MLA	An, Yuan,et al."The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study".CLINICAL RHEUMATOLOGY 36(2017):35-43.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。